Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Discovery of new biological principle can give better cancer treatment

13.09.2004


Pioneering research on leukaemia cells can have identified their vulnerable spot. This new knowledge can now be used to produce more effective medicines.



A group of scientists at the University of Bergen and Haukeland University Hospital made a surprising discovery when they stimulated leukaemia cells with the growth hormone GM-CSF. The reaction of the cells surprised everyone and would seem to indicate that scientists in Bergen have uncovered a new biological principle and consequently, a new therapeutic goal.

"We shouted, and expected to get one reply, but what we got was a bellow from an entire football team," says Project Leader Bjørn Tore Gjertsen, who was recently presented in the renowned American periodical Cell.


Hugely important discovery for cancer patients

Cell membranes contain receptors that are stimulated by a number of environmental factors, among them hormones. This starts a chain reaction between proteins that can in cancer cells result in increased production of substances that hamper necrocytosis (cell death) and encourage cancer. A mutation in receptor Flt3 and how this activates the chain reaction has previously been paid a lot of attention. In the tests carried out by Gjertsen and his fellow scientists, it was the GM-CSF receptor that captured their attention. Patients with Flt3 mutation showed an enormous reaction, in proteins that should in principle be normal. This indicates that the attack should be mounted here, if one is to find effective but gentle methods of cancer treatment.

"We have used tests from thirty patients with an acute type of spinal leukaemia. Compared to young people with lymphatic leukaemia, these patients have little chance of recovery. Life expectancy without treatment is about 2-3 months and only 20 percent are cured by chemotherapy. The study results can in principle also be applied to other types of cancer cells, so these results can prove to be of great importance for future cancer sufferers," says Gjertsen.

In this particular research project, Gjertsen has collaborated with colleagues from Stanford University and also several from the research milieu in Bergen, including Randi Hovland and Øystein Bruserud. With support from the cancer association, Bruserud has over the last twelve years, collected an invaluable bank of leukaemia tests. The Americans were contacted because they have developed a quick method for looking at the activation of proteins with the help of an antibody produced by mice.

"We have invaluable profiles that give us a comprehensive picture of what happens inside the cells. In spite of the huge amount of scientific research on cancer during the last ten years, there have been few important clinical results. This is mainly due to the fact that we have turned one stone at a time and studied the building blocks of the cancer cells individually. In system biology we try to look for patterns so that we can get a complete and realistic overall picture," says Gjertsen, "and adds that the use of cells collected from patients, and not static cell lines, can be the only way to get secure results."

The collaboration now continues with unabated strength, searching for energized key cancer proteins that lie under the signal line studied in the Cell article.

Bjørn Tore Gjertsen | alfa
Further information:
http://www.helse-bergen.no
http://www.forskningsradet.no

More articles from Life Sciences:

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>